시장조사 보고서 : 세계의 혈우병 치료제 시장예측 2021년-2026년

■ 영문 제목 : Global Hemophilia Therapeutics Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K00121 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 혈우병 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (혈우병 A, 혈우병 B, 혈우병 C)와 용도별 시장규모 (병원, 클리닉, 외래 외과 센터) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 혈우병 치료제 시장 점유율
- 지역별 혈우병 치료제 시장규모
- 주요지역의 종류별 시장규모 (혈우병 A, 혈우병 B, 혈우병 C)
- 주요지역의 용도별 시장규모 (병원, 클리닉, 외래 외과 센터)
- 미주의 혈우병 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 혈우병 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 혈우병 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 혈우병 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 혈우병 치료제 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Bayer AG, Pfizer, Inc., Novo Nordisk A/S, Baxter International Inc., Biogen Idec, Inc., Genetics Institute, Alpha Therapeutics Corporation, Expression Therapeutics, Swedish Orphan Biovitrum AB.
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Hemophilia Therapeutics will have significant change from previous year. By the most conservative estimates of global Hemophilia Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 9275.3 million in 2020. Over the next five years the Hemophilia Therapeutics market will register a 5.2% CAGR in terms of revenue, the global market size will reach US$ 11380 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemophilia Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Hemophilia A
Hemophilia B
Hemophilia C

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Clinics
Ambulatory Surgical Centers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer AG
Pfizer, Inc.
Novo Nordisk A/S
Baxter International Inc.
Biogen Idec, Inc.
Genetics Institute
Alpha Therapeutics Corporation
Expression Therapeutics
Swedish Orphan Biovitrum AB.

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemophilia Therapeutics Market Size 2016-2026
2.1.2 Hemophilia Therapeutics Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Hemophilia Therapeutics Segment by Type
2.2.1 Hemophilia A
2.2.2 Hemophilia A
2.2.3 Hemophilia C
2.3 Hemophilia Therapeutics Market Size by Type
2.3.1 Global Hemophilia Therapeutics Market Size CAGR by Type
2.3.2 Global Hemophilia Therapeutics Market Size Market Share by Type (2016-2021)
2.4 Hemophilia Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.5 Hemophilia Therapeutics Market Size by Application
2.5.1 Global Hemophilia Therapeutics Market Size CAGR by Application
2.5.2 Global Hemophilia Therapeutics Market Size Market Share by Application (2016-2021)

3 Hemophilia Therapeutics Market Size by Players
3.1 Hemophilia Therapeutics Market Size Market Share by Players
3.1.1 Global Hemophilia Therapeutics Revenue by Players (2019-2021E)
3.1.2 Global Hemophilia Therapeutics Revenue Market Share by Players (2019-2021E)
3.2 Global Hemophilia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Hemophilia Therapeutics by Regions
4.1 Hemophilia Therapeutics Market Size by Regions (2016-2021)
4.2 Americas Hemophilia Therapeutics Market Size Growth (2016-2021)
4.3 APAC Hemophilia Therapeutics Market Size Growth (2016-2021)
4.4 Europe Hemophilia Therapeutics Market Size Growth (2016-2021)
4.5 Middle East & Africa Hemophilia Therapeutics Market Size Growth (2016-2021)

5 Americas
5.1 Americas Hemophilia Therapeutics Market Size by Country (2016-2021)
5.2 Americas Hemophilia Therapeutics Market Size by Type (2016-2021)
5.3 Americas Hemophilia Therapeutics Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hemophilia Therapeutics Market Size by Region (2016-2021)
6.2 APAC Hemophilia Therapeutics Market Size by Type (2016-2021)
6.3 APAC Hemophilia Therapeutics Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hemophilia Therapeutics by Country (2016-2021)
7.2 Europe Hemophilia Therapeutics Market Size by Type (2016-2021)
7.3 Europe Hemophilia Therapeutics Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hemophilia Therapeutics by Region (2016-2021)
8.2 Middle East & Africa Hemophilia Therapeutics Market Size by Type (2016-2021)
8.3 Middle East & Africa Hemophilia Therapeutics Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Hemophilia Therapeutics Market Forecast
10.1 Global Hemophilia Therapeutics Forecast by Regions (2021-2026)
10.1.1 Global Hemophilia Therapeutics Forecast by Regions (2021-2026)
10.1.2 Americas Hemophilia Therapeutics Forecast
10.1.3 APAC Hemophilia Therapeutics Forecast
10.1.4 Europe Hemophilia Therapeutics Forecast
10.1.5 Middle East & Africa Hemophilia Therapeutics Forecast
10.2 Americas Hemophilia Therapeutics Forecast by Countries (2021-2026)
10.2.1 United States Hemophilia Therapeutics Market Forecast
10.2.2 Canada Hemophilia Therapeutics Market Forecast
10.2.3 Mexico Hemophilia Therapeutics Market Forecast
10.2.4 Brazil Hemophilia Therapeutics Market Forecast
10.3 APAC Hemophilia Therapeutics Forecast by Region (2021-2026)
10.3.1 China Hemophilia Therapeutics Market Forecast
10.3.2 Japan Hemophilia Therapeutics Market Forecast
10.3.3 Korea Hemophilia Therapeutics Market Forecast
10.3.4 Southeast Asia Hemophilia Therapeutics Market Forecast
10.3.5 India Hemophilia Therapeutics Market Forecast
10.3.6 Australia Hemophilia Therapeutics Market Forecast
10.4 Europe Hemophilia Therapeutics Forecast by Country (2021-2026)
10.4.1 Germany Hemophilia Therapeutics Market Forecast
10.4.2 France Hemophilia Therapeutics Market Forecast
10.4.3 UK Hemophilia Therapeutics Market Forecast
10.4.4 Italy Hemophilia Therapeutics Market Forecast
10.4.5 Russia Hemophilia Therapeutics Market Forecast
10.5 Middle East & Africa Hemophilia Therapeutics Forecast by Region (2021-2026)
10.5.1 Egypt Hemophilia Therapeutics Market Forecast
10.5.2 South Africa Hemophilia Therapeutics Market Forecast
10.5.3 Israel Hemophilia Therapeutics Market Forecast
10.5.4 Turkey Hemophilia Therapeutics Market Forecast
10.5.5 GCC Countries Hemophilia Therapeutics Market Forecast
10.6 Global Hemophilia Therapeutics Forecast by Type (2021-2026)
10.7 Global Hemophilia Therapeutics Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Bayer AG
11.1.1 Bayer AG Company Information
11.1.2 Bayer AG Hemophilia Therapeutics Product Offered
11.1.3 Bayer AG Hemophilia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Bayer AG Main Business Overview
11.1.5 Bayer AG Latest Developments
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Information
11.2.2 Pfizer, Inc. Hemophilia Therapeutics Product Offered
11.2.3 Pfizer, Inc. Hemophilia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Pfizer, Inc. Main Business Overview
11.2.5 Pfizer, Inc. Latest Developments
11.3 Novo Nordisk A/S
11.3.1 Novo Nordisk A/S Company Information
11.3.2 Novo Nordisk A/S Hemophilia Therapeutics Product Offered
11.3.3 Novo Nordisk A/S Hemophilia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Novo Nordisk A/S Main Business Overview
11.3.5 Novo Nordisk A/S Latest Developments
11.4 Baxter International Inc.
11.4.1 Baxter International Inc. Company Information
11.4.2 Baxter International Inc. Hemophilia Therapeutics Product Offered
11.4.3 Baxter International Inc. Hemophilia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Baxter International Inc. Main Business Overview
11.4.5 Baxter International Inc. Latest Developments
11.5 Biogen Idec, Inc.
11.5.1 Biogen Idec, Inc. Company Information
11.5.2 Biogen Idec, Inc. Hemophilia Therapeutics Product Offered
11.5.3 Biogen Idec, Inc. Hemophilia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Biogen Idec, Inc. Main Business Overview
11.5.5 Biogen Idec, Inc. Latest Developments
11.6 Genetics Institute
11.6.1 Genetics Institute Company Information
11.6.2 Genetics Institute Hemophilia Therapeutics Product Offered
11.6.3 Genetics Institute Hemophilia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Genetics Institute Main Business Overview
11.6.5 Genetics Institute Latest Developments
11.7 Alpha Therapeutics Corporation
11.7.1 Alpha Therapeutics Corporation Company Information
11.7.2 Alpha Therapeutics Corporation Hemophilia Therapeutics Product Offered
11.7.3 Alpha Therapeutics Corporation Hemophilia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Alpha Therapeutics Corporation Main Business Overview
11.7.5 Alpha Therapeutics Corporation Latest Developments
11.8 Expression Therapeutics
11.8.1 Expression Therapeutics Company Information
11.8.2 Expression Therapeutics Hemophilia Therapeutics Product Offered
11.8.3 Expression Therapeutics Hemophilia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Expression Therapeutics Main Business Overview
11.8.5 Expression Therapeutics Latest Developments
11.9 Swedish Orphan Biovitrum AB.
11.9.1 Swedish Orphan Biovitrum AB. Company Information
11.9.2 Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Product Offered
11.9.3 Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Swedish Orphan Biovitrum AB. Main Business Overview
11.9.5 Swedish Orphan Biovitrum AB. Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Hemophilia Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Hemophilia A
Table 3. Major Players of Hemophilia B
Table 4. Major Players of Hemophilia C
Table 5. Hemophilia Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Hemophilia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Hemophilia Therapeutics Market Size Market Share by Type (2016-2021)
Table 8. Hemophilia Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Hemophilia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Hemophilia Therapeutics Market Size Market Share by Application (2016-2021)
Table 11. Global Hemophilia Therapeutics Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Hemophilia Therapeutics Revenue Market Share by Players (2019-2021E)
Table 13. Hemophilia Therapeutics Key Players Head office and Products Offered
Table 14. Hemophilia Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hemophilia Therapeutics Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Hemophilia Therapeutics Market Size Market Share by Regions 2016-2021
Table 19. Americas Hemophilia Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Hemophilia Therapeutics Market Size Market Share by Country (2016-2021)
Table 21. Americas Hemophilia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Hemophilia Therapeutics Market Size Market Share by Type (2016-2021)
Table 23. Americas Hemophilia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Hemophilia Therapeutics Market Size Market Share by Application (2016-2021)
Table 25. APAC Hemophilia Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Hemophilia Therapeutics Market Size Market Share by Region (2016-2021)
Table 27. APAC Hemophilia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Hemophilia Therapeutics Market Size Market Share by Type (2016-2021)
Table 29. APAC Hemophilia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Hemophilia Therapeutics Market Size Market Share by Application (2016-2021)
Table 31. Europe Hemophilia Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Hemophilia Therapeutics Market Size Market Share by Country (2016-2021)
Table 33. Europe Hemophilia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Hemophilia Therapeutics Market Size Market Share by Type (2016-2021)
Table 35. Europe Hemophilia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Hemophilia Therapeutics Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Hemophilia Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Hemophilia Therapeutics Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Hemophilia Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Hemophilia Therapeutics Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Hemophilia Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Hemophilia Therapeutics Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Hemophilia Therapeutics
Table 44. Key Application and Potential Industries of Hemophilia Therapeutics
Table 45. Key Challenges of Hemophilia Therapeutics
Table 46. Key Trends of Hemophilia Therapeutics
Table 47. Global Hemophilia Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Hemophilia Therapeutics Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Hemophilia Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Hemophilia Therapeutics Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Hemophilia Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Hemophilia Therapeutics Market Size Market Share Forecast by Application (2021-2026)
Table 53. Bayer AG Details, Company Type, Hemophilia Therapeutics Area Served and Its Competitors
Table 54. Bayer AG Hemophilia Therapeutics Product Offered
Table 55. Bayer AG Hemophilia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Bayer AG Main Business
Table 57. Bayer AG Latest Developments
Table 58. Pfizer, Inc. Details, Company Type, Hemophilia Therapeutics Area Served and Its Competitors
Table 59. Pfizer, Inc. Hemophilia Therapeutics Product Offered
Table 60. Pfizer, Inc. Main Business
Table 61. Pfizer, Inc. Hemophilia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Pfizer, Inc. Latest Developments
Table 63. Novo Nordisk A/S Details, Company Type, Hemophilia Therapeutics Area Served and Its Competitors
Table 64. Novo Nordisk A/S Hemophilia Therapeutics Product Offered
Table 65. Novo Nordisk A/S Main Business
Table 66. Novo Nordisk A/S Hemophilia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Novo Nordisk A/S Latest Developments
Table 68. Baxter International Inc. Details, Company Type, Hemophilia Therapeutics Area Served and Its Competitors
Table 69. Baxter International Inc. Hemophilia Therapeutics Product Offered
Table 70. Baxter International Inc. Main Business
Table 71. Baxter International Inc. Hemophilia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Baxter International Inc. Latest Developments
Table 73. Biogen Idec, Inc. Details, Company Type, Hemophilia Therapeutics Area Served and Its Competitors
Table 74. Biogen Idec, Inc. Hemophilia Therapeutics Product Offered
Table 75. Biogen Idec, Inc. Main Business
Table 76. Biogen Idec, Inc. Hemophilia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Biogen Idec, Inc. Latest Developments
Table 78. Genetics Institute Details, Company Type, Hemophilia Therapeutics Area Served and Its Competitors
Table 79. Genetics Institute Hemophilia Therapeutics Product Offered
Table 80. Genetics Institute Main Business
Table 81. Genetics Institute Hemophilia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Genetics Institute Latest Developments
Table 83. Alpha Therapeutics Corporation Details, Company Type, Hemophilia Therapeutics Area Served and Its Competitors
Table 84. Alpha Therapeutics Corporation Hemophilia Therapeutics Product Offered
Table 85. Alpha Therapeutics Corporation Main Business
Table 86. Alpha Therapeutics Corporation Hemophilia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Alpha Therapeutics Corporation Latest Developments
Table 88. Expression Therapeutics Details, Company Type, Hemophilia Therapeutics Area Served and Its Competitors
Table 89. Expression Therapeutics Hemophilia Therapeutics Product Offered
Table 90. Expression Therapeutics Main Business
Table 91. Expression Therapeutics Hemophilia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Expression Therapeutics Latest Developments
Table 93. Swedish Orphan Biovitrum AB. Details, Company Type, Hemophilia Therapeutics Area Served and Its Competitors
Table 94. Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Product Offered
Table 95. Swedish Orphan Biovitrum AB. Main Business
Table 96. Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Swedish Orphan Biovitrum AB. Latest Developments
List of Figures
Figure 1. Hemophilia Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hemophilia Therapeutics Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Hemophilia Therapeutics Market Size Market Share by Type in 2020
Figure 7. Hemophilia Therapeutics in Hospitals
Figure 8. Global Hemophilia Therapeutics Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Hemophilia Therapeutics in Clinics
Figure 10. Global Hemophilia Therapeutics Market: Clinics (2016-2021) & ($ Millions)
Figure 11. Hemophilia Therapeutics in Ambulatory Surgical Centers
Figure 12. Global Hemophilia Therapeutics Market: Ambulatory Surgical Centers (2016-2021) & ($ Millions)
Figure 13. Global Hemophilia Therapeutics Market Size Market Share by Application in 2020
Figure 14. Global Hemophilia Therapeutics Revenue Market Share by Player in 2020
Figure 15. Global Hemophilia Therapeutics Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Hemophilia Therapeutics Market Size 2016-2021 ($ Millions)
Figure 17. APAC Hemophilia Therapeutics Market Size 2016-2021 ($ Millions)
Figure 18. Europe Hemophilia Therapeutics Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Hemophilia Therapeutics Market Size 2016-2021 ($ Millions)
Figure 20. Americas Hemophilia Therapeutics Market Size Market Share by Country in 2020
Figure 21. Americas Hemophilia Therapeutics Market Size Market Share by Type in 2020
Figure 22. Americas Hemophilia Therapeutics Market Size Market Share by Application in 2020
Figure 23. United States Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Hemophilia Therapeutics Market Size Market Share by Regions in 2020
Figure 27. APAC Hemophilia Therapeutics Market Size Market Share by Type in 2020
Figure 28. APAC Hemophilia Therapeutics Market Size Market Share by Application in 2020
Figure 29. China Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Hemophilia Therapeutics Market Size Market Share by Country in 2020
Figure 36. Europe Hemophilia Therapeutics Market Size Market Share by Type in 2020
Figure 37. Europe Hemophilia Therapeutics Market Size Market Share by Application in 2020
Figure 38. Germany Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Hemophilia Therapeutics Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Hemophilia Therapeutics Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Hemophilia Therapeutics Market Size Market Share by Application in 2020
Figure 46. Egypt Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Hemophilia Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 52. APAC Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 53. Europe Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 55. United States Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 56. Canada Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 59. China Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 60. Japan Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 61. Korea Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 63. India Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 64. Australia Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 65. Germany Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 66. France Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 67. UK Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 68. Italy Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 69. Russia Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 70. Spain Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 73. Israel Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Hemophilia Therapeutics Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 혈우병 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K00121) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 혈우병 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 혈우병 유전자 치료 시장예측 2021년-2026년
LPI-2201K00120 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 유전자 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hemophilia Gene Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia Gene Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 혈우병 A 및 B 재조합 인자 대체 요법 시장예측 2021년-2026년
LPI-2201K00119 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 재조합 인자 대체 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아,...According to this latest study, the 2021 growth of Hemophilia A and B Recombinant Factor Replacement Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia A and B Recombinant Factor Replacement Therapy market size (most likely outcome) will be a year-over-year revenue growth...

세계의 표적 단백질 분해 치료제 시장예측 2021년-2026년
LPI-2201K02312 / LP Information / 2021년 12월 / 본 조사보고서는 표적 단백질 분해 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Targeted-protein Degradation Therapeutics will have significant change from previous year. By the most conservative estimates of global Targeted-protein Degradation Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 혈우병 A 및 B 치료제 시장예측 2021년-2026년
LPI-2201K00221 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Hemophillia A and B Therapeutics Materials will have significant change from previous year. By the most conservative estimates of global Hemophillia A and B Therapeutics Materials market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in...

세계의 올리고뉴클레오티드 치료제 시장예측 2021년-2026년
LPI-2201K02248 / LP Information / 2021년 12월 / 본 조사보고서는 올리고뉴클레오티드 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Oligonucleotide Therapeutics will have significant change from previous year. By the most conservative estimates of global Oligonucleotide Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3083.2 million in 2020. Over...

세계의 마이크로바이옴 치료 및 진단 시장예측 2021년-2026년
LPI-2201K02344 / LP Information / 2021년 12월 / 본 조사보고서는 마이크로바이옴 치료 및 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Microbiome Therapeutics and Diagnostics will have significant change from previous year. By the most conservative estimates of global Microbiome Therapeutics and Diagnostics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX...

세계의 혈장 단백질 치료제 시장예측 2021년-2026년
LPI-2201K02150 / LP Information / 2021년 12월 / 본 조사보고서는 혈장 단백질 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Plasma Protein Therapeutics will have significant change from previous year. By the most conservative estimates of global Plasma Protein Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 25710 million in...

세계의 소양증 치료제 시장예측 2021년-2026년
LPI-2201K02285 / LP Information / 2021년 12월 / 본 조사보고서는 소양증 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pruritus Therapeutics will have significant change from previous year. By the most conservative estimates of global Pruritus Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 12760 million in 2020. Over...